US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Age Back

Reason CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Herbal Doctor Remedies D-1108-2020
Class II · Moderate risk Terminated

Acne Off

Reason CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Herbal Doctor Remedies D-1107-2020
Class II · Moderate risk Terminated

Acne Cystic

Reason CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Herbal Doctor Remedies D-1106-2020
Class II · Moderate risk Terminated

Acupuncture

Reason CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Herbal Doctor Remedies D-1105-2020
Class II · Moderate risk Terminated

Dermatone

Reason Microbial contamination of non-sterile products: positive test for yeast and bacteria.

Filltech USA, LLC D-1242-2020
Class II · Moderate risk Terminated

Dermatone

Reason Microbial contamination of non-sterile products: positive test for yeast and bacteria.

Filltech USA, LLC D-1241-2020
Class II · Moderate risk Terminated

Draximage Dtpa

Reason Failed Stability Specifications

Jubilant Draximage Inc NDC 65174-288-05 D-1062-2020
Class II · Moderate risk Terminated

Nystatin Oral Suspension

Reason SubPotent Drug: Low out-of-specification results for assay testing.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0810-16 D-1060-2020
Class II · Moderate risk Terminated

Methotrexate

Reason Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Edge Pharma, LLC D-0226-2021
Class II · Moderate risk Terminated

Oxycodone and Acetaminophen Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-046-01 D-1237-2020
Class II · Moderate risk Terminated

Phentermine Hydrochloride Capsules

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-105-01 D-1236-2020
Class II · Moderate risk Terminated

Mirtazapine Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-031-34 D-1235-2020
Class II · Moderate risk Terminated

Simvastatin Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 65862-053-90 D-1234-2020
Class II · Moderate risk Terminated

Levetiracetam Tablets USP 750 mg 120-count bottles

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 65862-247-08 D-1233-2020
Class II · Moderate risk Terminated

Gabapentin Capsules

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 65862-198-99 D-1232-2020
Class II · Moderate risk Terminated

Acetaminophen and Codeine Phosphate Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-060-01 D-1231-2020
Class II · Moderate risk Terminated

Acetaminophen and Codeine Phosphate Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-059-99 D-1230-2020
Class II · Moderate risk Terminated

Acetaminophen and Codeine Phosphate Tablets

Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Aurobindo Pharma USA Inc. NDC 13107-058-01 D-1229-2020
Class II · Moderate risk Terminated

fentaNYL Citrate Injection 50 mcg per mL

Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.

PharMEDium Services, LLC NDC 61553-303-28 D-1093-2020
Class II · Moderate risk Terminated

fentaNYL Citrate Injection

Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.

PharMEDium Services, LLC NDC 61553-306-33 D-1092-2020
Class II · Moderate risk Terminated

ePHEDrine Sulfate 5 mg per mL 25 mg per 5 mL

Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.

PharMEDium Services, LLC NDC 71030-003-02 D-1090-2020
Class II · Moderate risk Terminated

fentaNYL Citrate 50 mcg per mL

Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.

PharMEDium Services, LLC NDC 61553-672-44 D-1089-2020
Class II · Moderate risk Terminated

ePHEDrine Sulfate

Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.

PharMEDium Services, LLC NDC 71030-003-09 D-1088-2020